VFYVITRAFY LIFE SCIENCES LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 4 Aug 2026, 18:23 | FY26 Corporate Governance Statement | Company Administration | — | 03024 | |
| 4 Aug 2026, 18:23 | FY26 Appendix 4G | Company Administration | — | 03025 | |
| 4 Aug 2026, 18:23 | FY26 Full Year Results Presentation | Financial Results | MS | 03003, 03026 | |
| 4 Aug 2026, 18:22 | FY26 Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 3 Aug 2026, 23:36 | Vitrafy FY26 Investor Briefing | Presentations | — | 03027, 14014 | |
| 29 July 2026, 18:29 | Q4 FY26 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 23 July 2026, 18:29 | Vitrafy enters a partnership with Hoxworth Blood Center | Company Update | MS | 11001 | |
| 22 July 2026, 18:26 | Application for quotation of securities - VFY | Other | — | 06020 | |
| 13 July 2026, 21:43 | Notification of cessation of securities - VFY | Other | — | 06027 | |
| 10 July 2026, 19:05 | Application for quotation of securities - VFY | Other | — | 06020 | |
| 9 July 2026, 19:31 | Change of Director's Interest Notice - Correction | Director Interests | — | 02009 | |
| 9 July 2026, 18:53 | Change of Director's Interest Notices | Director Interests | — | 02009 | |
| 9 July 2026, 18:21 | Application for quotation of securities - VFY | Other | — | 06020 | |
| 8 July 2026, 20:19 | Expiry of Voluntary Escrow Restrictions | Securities Administration | — | 06009 | |
| 8 July 2026, 18:25 | Results of Oversubscribed Share Purchase Plan | Capital Raising | — | 06017 | |
| 19 June 2026, 18:20 | Vitrafy Share Purchase Plan Opens - SPP Offer Booklet | Capital Raising | MS | 06017 | |
| 18 June 2026, 18:22 | Cleansing Notice | Securities Administration | — | 06018 | |
| 18 June 2026, 18:22 | Application for quotation of securities - VFY | Other | — | 06020 | |
| 12 June 2026, 19:33 | Proposed issue of securities - VFY | Securities Administration | — | 06013 | |
| 12 June 2026, 19:33 | Vitrafy Equity Raising Presentation | Presentations | MS | 03026 | |
| 12 June 2026, 19:32 | Vitrafy Placement Completion and SPP Announcement | Capital Raising | MS | 06003, 06017, 09014 | |
| 10 June 2026, 18:32 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 3 June 2026, 18:20 | Vitrafy Investor Presentation | Presentations | — | 03026 | |
| 2 June 2026, 20:08 | Vitrafy enters a partnership with Vitalant Innovation Center | Company Update | MS | 11001 | |
| 22 May 2026, 18:23 | Phase 2 USAISR Platelet Results Investor Briefing | Presentations | — | 14014 | |
| 22 May 2026, 18:23 | Phase 2 USAISR Platelet Results Investor Presentation | Presentations | MS | 03026 | |
| 22 May 2026, 18:20 | Final US Army Phase 2 Platelet Results | Company Update | MS | 11001, 14014 | |
| 28 Apr 2026, 18:22 | Quarterly Investor Briefing Presentation | Presentations | — | 03026 | |
| 28 Apr 2026, 18:21 | Q3 FY26 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 14014, 19003, 19008 | |
| 24 Apr 2026, 02:27 | Vitrafy Q3 FY26 Investor Briefing | Presentations | — | 03027, 14014 | |
| 8 Apr 2026, 18:23 | USAISR Completes Phase 2 Platelet Study | Company Update | MS | 11001 | |
| 26 Mar 2026, 19:14 | NWR Virtual Healthcare Conference Presentation | Presentations | — | 03026 | |
| 25 Mar 2026, 04:40 | Vitrafy to present at NWR Virtual Healthcare Conference | Company Administration | — | 12008 | |
| 19 Feb 2026, 22:09 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 4 Feb 2026, 19:25 | FY26 Half Year Results Presentation | Financial Results | MS | 03004, 03026 | |
| 4 Feb 2026, 19:25 | FY26 Appendix 4D and Half Year Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 3 Feb 2026, 19:18 | Vitrafy FY26 Half Year Investor Briefing | Presentations | — | 03027, 14014 | |
| 29 Jan 2026, 19:17 | Quarterly Investor Briefing Presentation | Presentations | — | 03026, 19007 | |
| 29 Jan 2026, 19:17 | Q2 FY26 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 14014, 19002, 19007 | |
| 29 Jan 2026, 01:22 | Vitrafy Q2 FY26 Investor Briefing | Other | — | 03027 | |
| 20 Jan 2026, 20:22 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 20 Jan 2026, 20:19 | Appointment of Independent Non-Executive Director | Company Administration | — | 12001 | |
| 19 Jan 2026, 23:56 | Change in substantial holding from RYD | Substantial Holders | — | 02002 | |
| 15 Jan 2026, 19:28 | IMV Strategic Commercial Agreement Investor Briefing | Company Administration | — | 12008 | |
| 15 Jan 2026, 19:24 | IMV Strategic Partnership Investor Presentation | Presentations | MS | 03026 | |
| 15 Jan 2026, 19:24 | Vitrafy Enters Strategic Commercial Agreement with IMV | Company Update | MS | 11001 | |
| 15 Dec 2025, 19:48 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 15 Dec 2025, 19:24 | Notification regarding unquoted securities - VFY | Other | — | 06021 | |
| 21 Nov 2025, 21:27 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 21 Nov 2025, 21:24 | Notification of cessation of securities - VFY | Other | — | 06027 |
1–50 of 65
1 / 2